The transaction values Corvette at an enterprise value of €120m, with an estimated net debt of €20m.
Recipharm is buying €100m worth of equity using 50 per cent cash and the rest via a convertible bond.
LBO Italia originally invested in Corvette in 2009. Since then its revenues have grow to net sales of €57.7m last year, with an EBITDA of €15m.
The deal is expected to close on October 1 this year.
LBO Italia invests in mid-market companies in Italy. Its sole shareholder is Europe Capital Partners V.
Other investments in LBO Italia’s portfolio includes Doctor Dentist and waste management business Gruppo Geotea.
Copyright © 2014 AltAssets